Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Rao

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Developmental Medicine and Child Neurology|April 1, 1975
Tay-Sachs disease: case reports with emphasis on chromatographic study of rectal biopsyJ G Rao, V Rama, K Srinivas, et al.
Archives of Biochemistry and Biophysics|August 15, 1985
Diethylpyrocarbonate inactivation of NAD-malic enzyme from Ascaris suumJ G Rao, B G Harris, P F Cook
Acta Neurochirurgica|October 27, 2001
Surgery for upper cervical spine instabilities in childrenB Meyer, U Vieweg, J G Rao, et al.
Acta Anatomica|January 1, 1997
Is elastic energy storage of quantitative relevance for the functional morphology of the human locomotor apparatus?H Witte, S Recknagel, J G Rao, et al.
Biochemistry|November 6, 1984
Determination of dissociation constants for enzyme-reactant complexes for NAD-malic enzyme by modulation of the thiol inactivation rateD M Kiick, B L Allen, J G Rao, et al.
British Journal of Clinical Pharmacology|December 5, 2015
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.
British Journal of Clinical Pharmacology|December 5, 2015
A multicentre open trial of labetalol in New ZealandG L Sanders, D M Davies, G M Gales, et al.
European Journal of Clinical Pharmacology|December 18, 1978
Labetalol, a cross-over double blind controlled trialG L Sanders, P A Routledge, J G Rao, et al.
European Journal of Clinical Pharmacology|March 11, 1977
Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertensionP A Routledge, L V Zrinzo, J G Rao, et al.
British Journal of Clinical Pharmacology|January 1, 1979
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Developmental Medicine and Child Neurology|April 1, 1975
Tay-Sachs disease: case reports with emphasis on chromatographic study of rectal biopsyJ G Rao, V Rama, K Srinivas, et al.
Archives of Biochemistry and Biophysics|August 15, 1985
Diethylpyrocarbonate inactivation of NAD-malic enzyme from Ascaris suumJ G Rao, B G Harris, P F Cook
Acta Neurochirurgica|October 27, 2001
Surgery for upper cervical spine instabilities in childrenB Meyer, U Vieweg, J G Rao, et al.
Acta Anatomica|January 1, 1997
Is elastic energy storage of quantitative relevance for the functional morphology of the human locomotor apparatus?H Witte, S Recknagel, J G Rao, et al.
Biochemistry|November 6, 1984
Determination of dissociation constants for enzyme-reactant complexes for NAD-malic enzyme by modulation of the thiol inactivation rateD M Kiick, B L Allen, J G Rao, et al.
British Journal of Clinical Pharmacology|December 5, 2015
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.
British Journal of Clinical Pharmacology|December 5, 2015
A multicentre open trial of labetalol in New ZealandG L Sanders, D M Davies, G M Gales, et al.
European Journal of Clinical Pharmacology|December 18, 1978
Labetalol, a cross-over double blind controlled trialG L Sanders, P A Routledge, J G Rao, et al.
European Journal of Clinical Pharmacology|March 11, 1977
Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertensionP A Routledge, L V Zrinzo, J G Rao, et al.
British Journal of Clinical Pharmacology|January 1, 1979
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.
Pageof 2